MSN Laboratories

MSN Laboratories was founded in 2003 and is one of the fastest growing pharmaceutical manufacturers of APIs and finished dosages in India. We have 18 API and 6 Finished dosage facilities & an integrated R&D Center located in Hyderabad. Our state-of-the-art facilities are accredited by USFDA, EU:GMP, WHO:Geneva, PIC/S, ANVISA, Invima and many other global approvals. With a product portfolio covering 35 major therapies including Oncology, MSN reaches out to millions of people in over 100 countries across North America, Europe, Latin America, CIS, Middle East, Africa & Asia. Our strengths are our world-class facilities, innovation driven R&D, strong IPM, commitment to quality, efficient supply chain and a team with proven track record. MSN is proud to launch 1st-in-the-World Generics for 16 state-of-the-art-medicines at affordable prices; file 920+ patents, 1171+ DMFs/CEPs , 2000 Formulation Dossiers & more than 40 ANDAs. With annual capacities over 12 Billion units for the Oral Solids, Injectibles and Oncologics, we support 300 partners across 100 countries in the API and Formulations business.